EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology

Kimberly Wolzak, Lisa Vermunt, Marta Del Campo, Marta Jorge-Oliva, Anna Maria van Ziel, Ka Wan Li, August B Smit, Alice Chen-Ploktkin, David J Irwin, Afina W Lemstra, Yolande Pijnenburg, Wiesje van der Flier und 7 weitere

Alzheimer's & Dementia · 2023

DOI: 10.1002/alz.12978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2023. Verfasst von Kimberly Wolzak und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Faculty of Science, Vrije Universiteit Amsterdam, Amsterda…. Hauptthemen laut MEDLINE: Lewy Body Disease, Alzheimer Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Cerebrospinal fluid (CSF) biomarkers for specific cellular disease processes are lacking for tauopathies. In this translational study we aimed to identify CSF biomarkers reflecting early tau pathology‐associated unfolded protein response (UPR) activation. METHODS We employed mass spectrometry proteomics and targeted immunoanalysis in a combination of biomarker discovery in primary mouse neurons in vitro and validation in patient CSF from two independent large multicentre cohorts (EMIF‐AD MBD, n = 310; PRIDE, n = 771). RESULTS First, we identify members of the protein disulfide isomerase (PDI) family in the neuronal UPR‐activated secretome and validate secretion upon tau aggregation in vitro. Next, we demonstrate that PDIA1 and PDIA3 levels correlate with total‐ and phosphorylated‐tau levels in CSF. PDIA1 levels are increased in CSF from AD patients compared to controls and patients with tau‐unrelated frontotemporal and Lewy body dementia (LBD). Highlights Neuronal unfolded protein response (UPR) activation induces the secretion of protein disulfide isomerases (PDIs) in vitro. PDIA1 is secreted upon tau aggregation in neurons in vitro. PDIA1 and PDIA3 levels correlate with total and phosphorylated tau levels in CSF. PDIA1 levels are increased in CSF from Alzheimer's disease (AD) patients compared to controls. PDIA1 levels are not increased in CSF from tau‐unrelated frontotemporal dementia (FTD) and Lewy body dementia (LBD) patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lewy Body DiseaseAlzheimer DiseaseAnimalsMicetau ProteinsProtein Disulfide-IsomerasesAmyloid beta-PeptidesPhosphorylationBiomarkersPeptide Fragments

Stichwörter der Autor:innen

Alzheimer's diseaseCSF biomarkerPDIUPRtau pathology

Substanzen

tau ProteinsProtein Disulfide-IsomerasesAmyloid beta-PeptidesBiomarkersPeptide Fragments

Autor:innen und Institutionen

  • Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Functional Genomics Section, Department of Human Genetics, Amsterdam University Medical Centers (UMC) location Vrije Universiteit, Amsterdam, the Netherlands.
  • Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.
  • Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam University Medical Centers (UMC) location Vrije Universiteit, Amsterdam, the Netherlands.
  • Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo- CEU, CEU Universities, Madrid, Spain.
  • Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.

Zitieren

APA

Wolzak, K., Vermunt, L., Campo, M. D., Jorge-Oliva, M., van Ziel, A. M., Li, K. W., Smit, A. B., Chen-Ploktkin, A., Irwin, D. J., Lemstra, A. W., Pijnenburg, Y., van der Flier, W., Zetterberg, H., Gobom, J., Blennow, K., Visser, P. J., Teunissen, C. E., Tijms, B. M., & Scheper, W. (2023). Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology. Alzheimer's & Dementia. https://doi.org/10.1002/alz.12978

Vancouver

Wolzak K, Vermunt L, Campo MD, Jorge-Oliva M, van Ziel AM, Li KW, et al. Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology. Alzheimer's & Dementia. 2023. doi:10.1002/alz.12978

BibTeX
@article{Wolzak2023,
  author = {Wolzak, Kimberly and Vermunt, Lisa and Campo, Marta Del and Jorge-Oliva, Marta and van Ziel, Anna Maria and Li, Ka Wan and Smit, August B and Chen-Ploktkin, Alice and Irwin, David J and Lemstra, Afina W and Pijnenburg, Yolande and van der Flier, Wiesje and Zetterberg, Henrik and Gobom, Johan and Blennow, Kaj and Visser, Pieter Jelle and Teunissen, Charlotte E and Tijms, Betty M and Scheper, Wiep},
  title = {Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  doi = {10.1002/alz.12978}
}
Kostenlos starten →